Paul is a partner at Telegraph Hill partners. Before joining THP, he was Head of Strategy and Corporate Development for Life Technologies in a number of key leadership positions. Dr. Grossman has led the acquisition or divestment of more than 25 businesses. Prior to joining Invitrogen, Dr. Grossman held a variety of leadership roles during his more than 20 years at Applied Biosystems, including research scientist, patent attorney, Vice President of Intellectual Property and Vice President of Strategy and Business Development.
Dr. Grossman received bachelors and Ph.D. degrees in chemical engineering from the University of California, Berkeley, a master’s degree in chemical engineering from the University of Virginia, and a J.D. from Santa Clara University School of Law.